GLP-1 International Pricing: Why Canada Is Cheaper

Last updated: April 2026

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.

Affiliate Disclosure: We may earn a commission when you purchase through our links. This does not affect our editorial independence.

Quick Answer

Wegovy's list price for both the injection pen and the pill is about $1,350 per month (2026) [https://www.noom.com/blog/weight-management/wegovy-cost-without-insurance/?srsltid=AfmBOoqGPhQKiQvaAqm_j3HOWpG1WtGmFDc1JklYiYmF5dkbtRd5J5kV].
Without insurance, cash-pay prices for the injection pen range from $199–$349 per month through NovoNordisk’s NovoCare Pharmacy (2026) [https://www.noom.com/blog/weight-management/wegovy-cost-without-insurance/?srsltid=AfmBOoqGPhQKiQvaAqm_j3HOWpG1WtGmFDc1JklYiYmF5dkbtRd5J5kV].
The Wegovy pill, approved in late 2025, has a cash-pay price of $149–$299 per month (2026) [https://www.noom.com/blog/weight-management/wegovy-cost-without-insurance/?srsltid=AfmBOoqGPhQKiQvaAqm_j3HOWpG1WtGmFDc1JklYiYmF5dkbtRd5J5kV].
With insurance, monthly costs can be $25–$150, varying by plan and coverage [https://www.noom.com/blog/weight-management/wegovy-cost-without-insurance/?srsltid=AfmBOoqGPhQKiQvaAqm_j3HOWpG1WtGmFDc1JklYiYmF5dkbtRd5J5kV].

Understanding the cost of GLP-1 medications like Wegovy is crucial for anyone considering this treatment for weight management. In 2026, the list price for Wegovy, whether it's the weekly injection pen or the daily pill, stands at approximately $1,350 per month. However, what people actually pay can vary significantly based on insurance coverage, manufacturer programs, and pharmacy choices. For those without insurance, cash-pay prices have shifted, with the injection pen typically costing between $199 and $349 per month, and the newly approved Wegovy pill ranging from $149 to $299 per month through NovoNordisk’s NovoCare Pharmacy. Insurance coverage can dramatically reduce these expenses, often bringing monthly costs down to $25–$150, though coverage for weight loss medications is not always guaranteed and varies widely by plan. Staying informed about these shifting prices and available savings options is essential for making an informed decision about Wegovy.

What is the List Price of Wegovy?

The list price of Wegovy in 2026 is approximately $1,350 per month. This figure applies universally to both the weekly injection pen and the newer daily pill formulation of the medication. This list price is the official, publicly available price set by the manufacturer before any discounts, insurance coverage, or savings programs are applied.

Understanding the Manufacturer's Price

The manufacturer sets the list price for Wegovy, which is about $1,350 per month for both the injection pen and the pill [https://www.noom.com/blog/weight-management/wegovy-cost-without-insurance/?srsltid=AfmBOoqGPhQKiQvaAqm_j3HOWpG1WtGmFDc1JklYiYmF5dkbtRd5J5kV]. This price does not reflect what most patients actually pay. Instead, it serves as a baseline from which various reductions, such as insurance co-pays, deductibles, and manufacturer coupons, are calculated. The list price is an important starting point for understanding the overall cost structure of the medication. For many people, the idea of paying $1,350 out-of-pocket each month for a medication can seem daunting, which is why exploring all available savings avenues is so critical. It is also important to remember that this list price is subject to change as market conditions, government regulations, and manufacturer strategies evolve over time. The approval of the new Wegovy pill in late 2025 added another option for patients, but the list price remains consistent across both delivery methods.

Factors Influencing the Final Cost

While the list price provides a starting point, several factors ultimately determine what an individual will pay for Wegovy. These include the patient's specific insurance coverage, whether they qualify for manufacturer savings programs, and even the particular pharmacy they choose to use. The complexity of drug pricing means that a medication with a high list price might still be affordable for some patients due to these various mitigating factors. Conversely, without adequate insurance or access to savings programs, even a medication with a seemingly reasonable cash price can become a significant financial burden. Patients are encouraged to discuss these factors with their healthcare provider, pharmacist, and insurance company to get a clear picture of their personal financial responsibility. The goal is always to find the most cost-effective path to accessing necessary treatment.

The Role of Pharmacy Choice

The pharmacy a patient uses can also subtly influence the final price of Wegovy. Different pharmacies may have varying agreements with drug wholesalers or participate in different discount programs, leading to slight variations in cash-pay prices or even co-pay amounts. While these differences might not be as dramatic as those seen with insurance coverage or manufacturer coupons, they can still contribute to the overall affordability of the medication. It is always a good practice to compare prices at a few different pharmacies, especially for those paying out-of-pocket or with high deductibles. Some pharmacies might also offer their own loyalty programs or discount cards that can further reduce the cost.

How Much Does Wegovy Cost Without Insurance?

Without insurance, the cash-pay prices for Wegovy have become more accessible due to manufacturer programs. The Wegovy injection pen typically costs between $199 and $349 per month, while the newly approved Wegovy pill ranges from $149 to $299 per month. These specific cash prices are often available through NovoNordisk’s NovoCare Pharmacy, highlighting the impact of direct manufacturer initiatives.

Cash-Pay Options for the Injection Pen

For individuals who do not have insurance coverage or whose plans do not cover weight-loss medications, the cash-pay price for the Wegovy injection pen in 2026 generally falls within the range of $199–$349 per month. This cost represents a significant reduction from the medication's list price of $1,350 per month. This lower cash price is primarily facilitated through programs like NovoNordisk’s NovoCare Pharmacy, which aims to make the medication more affordable for self-pay patients. These programs are crucial for expanding access to effective weight management treatments for those who might otherwise be unable to afford them. Patients should actively seek out these manufacturer-sponsored options to ensure they are getting the best possible price. The price can vary based on the specific pharmacy and any ongoing promotions, so it is always wise to inquire directly with the manufacturer's program or participating pharmacies. The availability of these lower cash prices reflects a changing landscape in drug pricing, where manufacturers are increasingly offering direct-to-consumer options to address affordability concerns.

Pricing for the New Wegovy Pill

The Wegovy pill, which received approval in late 2025, offers another option for patients, and its cash-pay price without insurance is also designed to be more affordable. For the pill, patients can expect to pay between $149 and $299 per month. This price point positions the pill as a potentially more cost-effective option compared to the injection pen for some patients, especially when considering the lower end of the price range. Like the injection pen, these prices are typically available through manufacturer programs such as NovoNordisk’s NovoCare Pharmacy. The introduction of the pill form provides patients with more choices, not only in terms of administration but also in terms of potential cost savings. The difference in price between the injection and pill forms could influence a patient's decision, depending on their budget and preference. It is important for patients to consider both the clinical suitability and the financial implications of each option when consulting with their healthcare provider. For more details, see Wegovy Cost & Coverage Information.

Navigating Uninsured and Self-Pay Scenarios

Navigating the cost of GLP-1 medications like Wegovy without insurance can be complex, but manufacturer programs are making it more manageable. The cash-pay prices offered through NovoNordisk’s NovoCare Pharmacy are a prime example of how patients can access Wegovy at a significantly reduced rate compared to the list price. It is essential for uninsured or self-pay patients to directly engage with these programs to understand their eligibility and the specific terms of the offers. These initiatives represent a concerted effort by manufacturers to mitigate the financial burden for patients who lack comprehensive insurance coverage for weight loss medications. The availability of these prices, ranging from $199–$349 for the injection pen and $149–$299 for the pill, means that effective weight management treatment can be within reach for a broader population.

Can Insurance Reduce Wegovy Costs?

Yes, insurance can significantly reduce Wegovy costs, with monthly prices often falling between $25 and $150. However, the exact amount depends heavily on the individual insurance plan and its specific coverage for weight loss medications. While coverage for weight loss is historically rare, the landscape is gradually shifting.

Typical Costs with Insurance Coverage

For patients with insurance, the estimated monthly cost for Wegovy, encompassing both the injection pen and the pill, typically ranges from $25 to $150. This is a substantial reduction from the list price of $1,350 per month. The exact amount a patient pays with insurance is influenced by several factors, including their plan's deductible, co-pay, and co-insurance structure. Some plans may offer more comprehensive coverage, leading to lower out-of-pocket costs, while others might have higher deductibles that need to be met before significant savings kick in. It is crucial for patients to contact their insurance provider directly to understand the specifics of their coverage for Wegovy. This includes asking about formulary status, any prior authorization requirements, and their expected co-pay or co-insurance. The variation in costs highlights the importance of individualized benefit checks.

The Challenge of Weight Loss Coverage

Historically, insurance plans have rarely covered medications specifically for weight loss. This has been a major barrier for many individuals seeking treatment for obesity. However, the situation is evolving. While some of that is changing, you’ll likely still pay out of pocket for Wegovy [https://www.noom.com/blog/weight-management/wegovy-cost-without-insurance/?srsltid=AfmBOoqGPhQKiQvaAqm_j3HOWpG1WtGmFDc1JklYiYmF5dkbtRd5J5kV]. More insurance companies are beginning to recognize obesity as a chronic disease requiring medical intervention, leading to an increase in coverage for GLP-1 medications like Wegovy. Despite this positive trend, coverage is still not universal, and many plans may have strict criteria, such as a high body mass index (BMI) or co-existing health conditions, before approving coverage. Patients should be prepared for the possibility of needing to appeal an initial denial of coverage or explore alternative payment methods if their plan does not cover weight loss medications.

Prior Authorization Requirements

Even when an insurance plan does cover Wegovy, patients often face prior authorization requirements. Prior authorization is a process where the healthcare provider must obtain approval from the insurance company before the medication can be dispensed. This typically involves submitting documentation that justifies the medical necessity of the treatment, such as the patient's BMI, weight loss history, and any obesity-related comorbidities. Navigating GLP-1 medications often involves prior authorization challenges. This process can be time-consuming and sometimes frustrating, but it is a common step for many high-cost or specialty medications. Tools like CoverMyMeds can help simplify the GLP-1 prior authorization process for providers by streamlining the submission of necessary paperwork. Patients should work closely with their healthcare provider's office to ensure all required documentation is submitted promptly and accurately to avoid delays in starting treatment.

The Shifting Landscape of Insurance Coverage

The landscape of insurance coverage for GLP-1 medications like Wegovy is dynamic. Government rules, regulations, and shifts in manufacturer programs continue to influence how insurance companies approach coverage for these drugs. As more research emerges on the long-term benefits of GLP-1s for overall health beyond just weight loss, it is possible that coverage will become even more widespread. Patients considering Wegovy should stay informed about these changes and regularly check with their insurance provider for the most up-to-date information on their plan's coverage. The current trend suggests a gradual increase in acceptance and coverage, but it remains a complex area with significant variations across different plans and regions.

What Are the Potential Side Effects of Wegovy?

Wegovy may cause serious side effects, including the potential for thyroid tumors, which can include cancer. Other significant risks include inflammation of the pancreas (pancreatitis) and gallbladder problems, such as gallstones. Patients must disclose all medical conditions and medications to their healthcare provider before starting Wegovy, as it can interact with other drugs and may not be suitable for everyone.

Serious Side Effects to Monitor

One of the most important pieces of information regarding Wegovy is its potential to cause serious side effects. Wegovy may cause serious side effects, including possible thyroid tumors, including cancer [https://www.wegovy.com/obesity/what-to-pay-for-wegovy.html]. Patients should immediately tell their healthcare provider if they notice a lump or swelling in their neck, experience hoarseness, have trouble swallowing, or feel short of breath, as these could be symptoms of thyroid cancer. Studies in rodents have shown that Wegovy and similar medications can cause thyroid tumors, including thyroid cancer, though it is not yet known if this risk applies to humans, specifically for a type of thyroid cancer called medullary thyroid carcinoma (MTC). Therefore, Wegovy should not be used by individuals or their families with a history of MTC or an endocrine condition known as Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). For more details, see Wegovy Cost Without Insurance in 2026.

Pancreatitis and Gallbladder Issues

Beyond thyroid concerns, Wegovy can also lead to inflammation of the pancreas, a condition known as pancreatitis. Patients should stop using Wegovy and contact their healthcare provider right away if they develop severe, persistent pain in their stomach area (abdomen), especially if it radiates to their back and is accompanied by nausea or vomiting. This type of pain needs immediate medical attention. Another serious potential side effect involves gallbladder problems, including the formation of gallstones. Some gallstones may become severe enough to require surgery. Symptoms of gallbladder issues include pain in the upper stomach, fever, yellowing of the skin or eyes (jaundice), or clay-colored stools. Any of these symptoms warrant prompt communication with a healthcare professional.

Important Precautions and Drug Interactions

Before starting Wegovy, it is crucial for patients to have a thorough discussion with their healthcare provider about their complete medical history. This includes any past or present problems with the pancreas or kidneys, a history of diabetic retinopathy if they have type 2 diabetes, or if they are scheduled for surgery requiring anesthesia. Women who are pregnant or planning to become pregnant should be aware that Wegovy may harm an unborn baby, and they should stop using the medication two months before planning conception. Breastfeeding is also not recommended during treatment with Wegovy tablets, as it is unknown if the injectable form passes into breast milk. Furthermore, patients must inform their doctor about all medicines they are currently taking, including prescription drugs, over-the-counter medications, vitamins, and herbal supplements. Wegovy can affect how other medicines work and vice versa. It is particularly important to mention if taking other diabetes medications like sulfonylureas or insulin. Because Wegovy slows stomach emptying, it can impact medicines that need to pass through the stomach quickly, potentially altering their effectiveness. A comprehensive review of all medications helps prevent adverse interactions and ensures the safe use of Wegovy.

Are There Savings Programs Available for Wegovy?

Yes, there are several savings programs available for Wegovy that can significantly reduce its cost. The manufacturer, NovoNordisk, offers programs like NovoCare Pharmacy, which provides lower cash-pay prices. Additionally, drug coupons found on prescription discount websites can save patients up to $55 per fill, and these can sometimes offer a lower price than what would be paid through insurance.

Manufacturer-Sponsored Savings

NovoNordisk, the manufacturer of Wegovy, provides programs designed to make the medication more affordable, especially for those without adequate insurance coverage. One notable initiative is NovoCare Pharmacy, which offers lower cash-pay prices for patients. For instance, without insurance, cash-pay prices in 2026 typically range from about $199–$349 per month for the injection pen and $149–$299 for the pill through NovoNordisk’s NovoCare Pharmacy. These programs are essential for bridging the gap between the high list price and what many patients can realistically afford. Patients interested in these programs should visit the official Wegovy website or contact NovoNordisk directly to check their eligibility and enroll. Such programs often have specific terms and conditions, so understanding the details is key to maximizing savings. The manufacturer's commitment to offering these lower-cost options highlights the ongoing effort to improve access to GLP-1 medications for weight management.

Prescription Discount Websites and Coupons

Beyond manufacturer programs, patients can also find savings through prescription discount websites. These platforms often offer drug coupons that can reduce the retail price of Wegovy. You may save up to $55 per fill off of the retail price of Wegovy [https://www.medicalnewstoday.com/articles/drugs-wegovy-cost]. While these coupons cannot be combined with insurance copays or benefits, the discounted price they offer may sometimes be even lower than what a patient would pay through their insurance plan. This makes them a valuable resource for both insured individuals with high deductibles or limited coverage and those paying entirely out-of-pocket. Patients should search these websites before filling their prescription to see what discounts are available. Comparing the coupon price with their insurance co-pay is a smart strategy to ensure they are getting the best possible deal. The retail price of Wegovy is $1349, so even a $55 saving per fill can add up over time, providing significant financial relief.

The Role of Pharmacy-Specific Programs

Some individual pharmacies may also offer their own savings programs or loyalty cards that can help reduce the cost of prescription medications, including Wegovy. While these are less common for high-cost specialty drugs, it is always worth inquiring at the pharmacy. Additionally, the specific pharmacy chosen can impact the final price. Factors that may affect the price you’ll pay include your treatment plan, your insurance coverage, and the pharmacy you use [https://www.medicalnewstoday.com/articles/drugs-wegovy-cost]. Different pharmacies might have varying agreements with drug suppliers or different pricing structures for cash-paying customers. Therefore, comparing prices across a few local pharmacies, in addition to exploring manufacturer and coupon programs, can help patients find the most affordable option for their Wegovy prescription.

What About Ozempic Savings for Type 2 Diabetes?

Ozempic, another semaglutide medication, offers various savings programs specifically for patients with type 2 diabetes. Commercially covered patients can pay as little as $25 for up to a three-month prescription through a savings card. Uninsured and self-pay patients also have access to limited-time offers, such as new patients paying $25 per month for the first two months of the lower doses.

Savings for Commercially Covered Patients

For patients with type 2 diabetes who have commercial insurance coverage, Ozempic offers a significant savings card program. Through this program, commercially covered patients can pay as little as $25 for any dose of Ozempic for up to a 3-month prescription [https://www.ozempic.com/savings-and-resources/save-on-ozempic.html]. This dramatically reduces the out-of-pocket cost, making the medication much more accessible. These savings cards typically work by covering a portion of the co-pay or co-insurance, bringing the patient's responsibility down to a minimal amount. Eligibility for these programs often depends on the patient's insurance type and whether they meet certain criteria, such as not being enrolled in government-funded healthcare programs like Medicare or Medicaid. Patients should visit the official Ozempic website to apply for and activate their savings card, ensuring they meet all the necessary requirements. This type of program is invaluable for managing the ongoing costs of a chronic condition like type 2 diabetes. For more details, see Wegovy Cost 2026: Coupons, Savings, and More.

Offers for Uninsured and Self-Pay Patients

Ozempic also extends savings opportunities to uninsured and self-pay patients, albeit often as limited-time offers. For new patients who are uninsured or self-pay, there is an offer to pay $25 per month for the first two months of Ozempic 0.25 mg or 0.5 mg. This initial discount helps new users start their treatment regimen without the immediate burden of the full cash price. While the research does not specify the ongoing prices for these patients after the initial two months or for existing patients, the availability of such introductory offers demonstrates a commitment to making Ozempic accessible beyond just those with commercial insurance. Patients in these categories should regularly check the Ozempic savings and resources page for the most current offers and eligibility criteria. These programs are particularly important for ensuring that financial barriers do not prevent individuals with type 2 diabetes from accessing effective treatment options.

Comparing Ozempic and Wegovy Savings

While both Ozempic and Wegovy are semaglutide medications from NovoNordisk, their primary indications and, consequently, their savings programs, are tailored differently. Ozempic is primarily indicated for type 2 diabetes, often with a secondary benefit of weight loss, while Wegovy is specifically approved for chronic weight management. The savings programs reflect these distinctions. Ozempic’s savings card for commercially covered patients is quite comprehensive, offering a very low co-pay for extended periods. Wegovy, on the other hand, focuses more on reducing the cash-pay price for uninsured patients or offering coupons that reduce the retail price, reflecting the challenges of insurance coverage for weight loss medications. Patients should identify which medication is appropriate for their specific health needs and then explore the corresponding savings programs. Consulting with a healthcare provider and a pharmacist can help clarify which program offers the best financial advantage based on individual circumstances and diagnosis.

Frequently Asked Questions

What is the average monthly cost of Wegovy without insurance in 2026?

Without insurance, the average monthly cost of Wegovy in 2026 can vary depending on the form of the medication. The Wegovy injection pen typically costs between $199 and $349 per month, while the newly approved Wegovy pill ranges from $149 to $299 per month. These prices are generally available through NovoNordisk’s NovoCare Pharmacy, which offers reduced cash-pay options compared to the list price.

Does insurance typically cover Wegovy for weight loss?

Insurance coverage for Wegovy for weight loss is not always guaranteed, but the situation is changing. Historically, insurance rarely accepted coverage for medications used solely for weight loss. However, with increasing recognition of obesity as a chronic disease, more plans are beginning to cover these medications. With insurance, estimated monthly prices can range from $25–$150, but coverage varies significantly by individual plan and often requires prior authorization.

What are the major side effects to be aware of when taking Wegovy?

Wegovy may cause serious side effects, including the risk of thyroid tumors, which could be cancerous. Patients should watch for symptoms like a neck lump, hoarseness, trouble swallowing, or shortness of breath. Other serious side effects include inflammation of the pancreas (pancreatitis) and gallbladder problems, such as gallstones. It's crucial to inform your doctor about all medical conditions and medications you take.

Are there manufacturer programs to help reduce the cost of Wegovy?

Yes, the manufacturer, NovoNordisk, offers programs to help reduce the cost of Wegovy. Through initiatives like NovoCare Pharmacy, patients can access lower cash-pay prices, ranging from $199–$349 for the injection pen and $149–$299 for the pill without insurance. Additionally, prescription discount websites may offer coupons that save up to $55 per fill off the retail price.

How does the cost of the Wegovy injection compare to the Wegovy pill?

In 2026, the list price for both the Wegovy injection pen and the newly approved daily pill is about $1,350 per month. However, without insurance, the cash-pay prices differ slightly. The injection pen typically costs $199–$349 per month, while the pill ranges from $149–$299 per month through NovoNordisk’s NovoCare Pharmacy. This makes the pill generally a bit more affordable on the cash-pay market.

— The The GLP-1 Daily Team